Sort
16,300 grants matching “fatty liver disease”
Orphan Nuclear Receptors in Lipid Metabolism and Inflammation
$385,000Peter J Tontonoz · University Of California Los Angeles · P01 · FY2019 · HL
Transcriptional control of microRNAs in lipid metabolism and atherosclerosis
$385,000Thomas A Vallim · University Of California Los Angeles · R01 · FY2017 · HL
Molecular Biology of Bile Acid Synthesis
$385,000John Y. Chiang · Northeast Ohio Medical University · R01 · FY2010 · DK
Symptom burden in End-Stage Liver Disease patient-caregiver dyads
$385,000Lissi Hansen · Oregon Health & Science University · R01 · FY2016 · NR
Novel Post-Transcriptional Regulators of Lipid Metabolism
$385,000Thomas A Vallim · University Of California Los Angeles · R01 · FY2018 · DK
Subtype Specific LXR Activity Limits Atherosclerosis
$385,000Ira G Schulman · University Of Virginia · R01 · FY2011 · HL
Adiponectin Actions on the Monocyte to Reduce Atherosclerosis
$385,000Rajendra K Tangirala · University Of California Los Angeles · R01 · FY2009 · HL
Novel Post-Transcriptional Regulators of Lipid Metabolism
$385,000Thomas A Vallim · University Of California Los Angeles · R01 · FY2017 · DK
Orphan Nuclear Receptors in Lipid Metabolism and Inflammation
$385,000Peter J Tontonoz · University Of California Los Angeles · P01 · FY2016 · HL
Orphan Nuclear Receptors in Lipid Metabolism and Inflammation
$385,000Peter J Tontonoz · University Of California Los Angeles · P01 · FY2017 · HL
Exploring the pathophysiology and treatment of LCHADD retinopathy
$385,000Melanie B Gillingham · Oregon Health & Science University · R01 · FY2025 · EY
Exploring the pathophysiology and treatment of LCHADD retinopathy
$385,000Melanie B Gillingham · Oregon Health & Science University · R01 · FY2023 · EY
Symptom burden in End-Stage Liver Disease patient-caregiver dyads
$385,000Lissi Hansen · Oregon Health & Science University · R01 · FY2017 · NR
Regulation of Bile Acid Synthesis by Nuclear Receptors
$385,000John Y. Chiang · Northeast Ohio Medical University · R37 · FY2011 · DK
Novel Post-Transcriptional Regulators of Lipid Metabolism
$385,000Thomas A Vallim · University Of California Los Angeles · R01 · FY2019 · DK
Transcriptional control of microRNAs in lipid metabolism and atherosclerosis
$385,000Thomas A Vallim · University Of California Los Angeles · R01 · FY2020 · HL
Subtype Specific LXR Activity Limits Atherosclerosis
$385,000Ira G Schulman · University Of Virginia · R01 · FY2010 · HL
Characterization of Diet1, a hypercholesterolemia resistance gene
$385,000Karen Reue · University Of California Los Angeles · R01 · FY2010 · HL
Adipokine Signaling in Macrophages
$385,000Ling Qi · Cornell University · R01 · FY2009 · DK
Adiponectin Actions on the Monocyte to Reduce Atherosclerosis
$385,000Rajendra K Tangirala · University Of California Los Angeles · R01 · FY2010 · HL
NASH Clinical Research Network
$385,000Anna Mae Elizabeth Diehl · Duke University · U01 · FY2016 · DK
Regulation of ApoB Lipoprotein Expansion and Hepatic Lipid Efflux by ApoA-IV
$385,000John S Parks · Wake Forest University Health Sciences · R01 · FY2014 · HL
Exploring the pathophysiology and treatment of LCHADD retinopathy
$385,000Melanie B Gillingham · Oregon Health & Science University · R01 · FY2024 · EY
Exploring the pathophysiology and treatment of LCHADD retinopathy
$385,000Melanie B Gillingham · Oregon Health & Science University · R01 · FY2021 · EY
Transcriptional control of microRNAs in lipid metabolism and atherosclerosis
$385,000Thomas A Vallim · University Of California Los Angeles · R01 · FY2019 · HL